These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3904855)

  • 21. Tumoricidal responses in spontaneous canine neoplasms after extracorporeal perfusion over immobilized protein A.
    Terman DS
    Fed Proc; 1981 Jan; 40(1):45-9. PubMed ID: 7450063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour immunotherapy: the adjuvant treatment of the 21st century?
    Bremers AJ; Kuppen PJ; Parmiani G
    Eur J Surg Oncol; 2000 Jun; 26(4):418-24. PubMed ID: 10873365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of T lymphocytes by protein A from Staphylococcus aureus in B-derived chronic lymphocytic leukaemia.
    Guglielmi P; Preud'Homme JL
    Clin Exp Immunol; 1980 Jul; 41(1):136-40. PubMed ID: 6969148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A trial of autologous plasma perfusion over protein A in patients with breast cancer.
    Fer MF; Beman J; Stevenson HC; Maluish A; Moratz C; Delawter T; Foon K; Herberman RB; Oldham RK; Terman DS
    J Biol Response Mod; 1984; 3(3):352-8. PubMed ID: 6235326
    [No Abstract]   [Full Text] [Related]  

  • 25. Lymphosarcoma and persistent feline leukemia virus infection of pet cats: a system to study responses during extracorporeal treatments.
    Jones FR; Grant CK; Snyder HW
    J Biol Response Mod; 1984; 3(3):286-92. PubMed ID: 6086847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein A-independent tumoricidal responses in dogs after extracorporeal perfusion of plasma over Staphylococcus aureus.
    Gordon BR; Matus RE; Saal SD; MacEwen EG; Hurvitz AI; Stenzel KH; Rubin AL
    J Natl Cancer Inst; 1983 Jun; 70(6):1127-33. PubMed ID: 6343694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunodeficiency and cancer: prospects for correction.
    Hadden JW
    Int Immunopharmacol; 2003 Aug; 3(8):1061-71. PubMed ID: 12860163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staphylococcal protein A immunoadsorptive column induces mitogenicity in perfused plasma.
    Bertram JH; Hengst JC; Mitchell MS
    J Biol Response Mod; 1984; 3(3):235-40. PubMed ID: 6379107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants.
    Morera Y; Bequet-Romero M; Ayala M; Lamdán H; Agger EM; Andersen P; Gavilondo JV
    Angiogenesis; 2008; 11(4):381-93. PubMed ID: 19034678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer immunity. The effect in cancer-immunotherapy of polymerised autologus tumour tissue and supportive measures.
    Tallberg T; Tykkä H; Halttunen P; Mahlberg K; Uusitalo R; Uusitalo H; Carlson O; Sandstedt B; Oravisto KJ; Lehtonen T
    Scand J Clin Lab Invest Suppl; 1979; 151():1-35. PubMed ID: 160076
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of ex-vivo plasma adsorption over protein A sepharose in acute leukemia.
    Solal-Celigny P; Simeon J; Herrera A; Vinci G; Bertrand O; Mahieu P; Kinet JP; Raspaud S; Sinegre M; Boivin P
    Leuk Res; 1986; 10(6):643-9. PubMed ID: 3520164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trials with staphylococcal protein A.
    Bensinger WI; Buckner CD; Clift RA; Thomas ED
    J Biol Response Mod; 1984; 3(3):347-51. PubMed ID: 6379119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressor control as a modality of cancer treatment: effect of plasma adsorption with Staphylococcus aureus protein A.
    Ray PK
    Contemp Top Immunobiol; 1985; 15():147-211. PubMed ID: 3161699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease.
    Dessureault S; Noyes D; Lee D; Dunn M; Janssen W; Cantor A; Sotomayor E; Messina J; Antonia SJ
    Ann Surg Oncol; 2007 Feb; 14(2):869-84. PubMed ID: 17103257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vitamin E: immunocorrecting effect in bronchial asthma patients].
    Pletsityĭ KD; Vasipa SB; Davydova TV; Fomina VG
    Vopr Med Khim; 1995; 41(4):33-6. PubMed ID: 8571584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical response to protein a-treated plasma infusions and in vitro correlation.
    MacKintosh FR; Bennett K; Hall SW
    J Biol Response Mod; 1984; 3(3):336-40. PubMed ID: 6379117
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase I evaluation of humanized OKT3: toxicity and immunomodulatory effects of hOKT3gamma4.
    Richards J; Auger J; Peace D; Gale D; Michel J; Koons A; Haverty T; Zivin R; Jolliffe L; Bluestone JA
    Cancer Res; 1999 May; 59(9):2096-101. PubMed ID: 10232594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative aspects of binding of canine serum immunoglobulins of Staphylococcus aureus protein A.
    Miele JA; Krakowka S
    Am J Vet Res; 1981 Dec; 42(12):2065-7. PubMed ID: 6803618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of plasma treatment with purified protein A and Staphylococcus aureus Cowan I on spontaneous animal neoplasms.
    Klausner JS; Miller WJ; O'Brien TD; Branda RF
    Cancer Res; 1985 Mar; 45(3):1263-9. PubMed ID: 3971372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.